Protagonist Therapeutics, Inc. PTGX
121.40 USD -2.62 (-2.11%)
Regular-session close
121.40 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
120.15 Day range 125.74
79.73 52-week range 158.62
- YTD
- +39.00%
- 1 year
- +44.18%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 46.02M | 434.43M | 60.00M | 26.58M | 27.36M | |
| 46.02M | 434.43M | 60.00M | 26.58M | 27.36M | |
| -158.13M | 252.84M | -93.65M | -131.37M | -125.84M | |
| -130.15M | 275.19M | -78.95M | -127.39M | -125.55M | |
| -2.05 | 4.23 | -1.39 | -2.60 | -2.71 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 128.39M | 97.25M | 186.73M | 125.74M | 123.67M | |
| 668.19M | 744.73M | 357.95M | 247.93M | 347.69M | |
| 53.48M | 69.43M | 21.27M | 32.32M | 47.67M | |
| 10.32M | 10.87M | 1.14M | 3.66M | 5.86M | |
| 614.71M | 675.29M | 336.68M | 215.61M | 300.02M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 57.67M | 184.15M | -70.24M | -108.14M | -107.86M | |
| -49.33M | -299.48M | -39.26M | 91.47M | -15.86M | |
| 22.86M | 25.85M | 170.48M | 18.84M | 129.92M | |
| -1.59M | -1.35M | -609.00K | -795.00K | -1.10M | |
| 31.20M | -89.48M | 60.98M | 2.08M | 6.07M |
